ArchivesMagazine - 28 Apr 2022Why Unilever has a 10.5% stake in this small cap drug developer AIM-quoted Arecor Therapeutics has a track record of partnering up with big pharma firms 28 April 2022|Feature|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < The best and worst first quarter performers in emerging markets Issue: 28 Apr 2022 - Page 29 | Contents Previous: The best and worst first quarter performers in emerging markets Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Ask Tom I’m retiring to the UK from overseas can I set up a SIPP? Editor's View There could be more pain to endure from rising oil prices Feature The companies able to charge more without hurting demand Explaining the poison pill defence which could have derailed Musk’s Twitter bid Great buying opportunities from the big tech rout Why Unilever has a 10.5% stake in this small cap drug developer The best and worst first quarter performers in emerging markets Emerging markets: Views from the experts How big property funds have performed and the different ways to invest Funds The majority of absolute return funds have lost investors money this year Great Ideas Smartly-timed sale and share buyback reveal Spectris’ hidden value Strong reasons to buy Strix, a global leader in niche market Brookfield and Homeserve in talks as broker says shares could be worth £15 Why B&M remains a great way to beat the squeeze Loungers maintains fast growth despite facing consumer headwinds Asia Dragon Trust goes shopping for stocks amid market sell-off News Shares in mining companies hurt by Chinese lockdowns and operational issues Can consumer-facing firms beat the big squeeze? Growth stocks continue to struggle as we reveal stocks at 52-week highs and lows Novacyt faces £134.6 million NHS legal claim Why language services group RWS could be the latest private equity victim Personal Finance Here are some reasons to be more cheerful about your money
